Generate Biomedicines Stock
HealthTechGenerate Biomedicines, a developer of a generative biology platform, is designed to innovate new drugs across protein modalities and protein therapeutics. They leverage machine learning on their platform to decode the genetic instructions controlling protein functions, enabling rapid production of antibodies, peptides, enzymes, as well as cell and gene therapies to fulfill any therapeutic requirement. This allows biologists to introduce fundamentally new treatments to patients.
Alumni Ventures, ARCH Venture Partners, Pictet Alternative Advisors, Flagship Pioneering, Partners Investment, Abu Dhabi Investment Authority, Fidelity Management & Research, Amgen, Alaska Permanent Fund, Modi Ventures, Altitude Life Science Ventures, NVentures (Santa Clara), Morningside Group, March Capital, Maps Capital, Mirae Asset Capital, T. Rowe Price.